Abzena

Overview

CDMO specializing in complex biologics and advanced modalities, where Campbell Bunce serves as Chief Scientific Officer. Abzena is a CDMO where Campbell Bunce serves as Chief Scientific Officer, focusing on translating complex science including novel advanced modalities into manufacturable and scalable therapeutics. Bunce, speaking from a CDMO perspective, advocates that the most important factor for success is choosing a CDMO that works collaboratively in a trust-sharing and risk-sharing way, with expertise across early design, lead selection, and manufacturing rather than one motivated to fill suite capacity. (Segment 1 (00:00-05:00))